Drugs / tocladesine

Trials 2

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00021268 Apr 2001 → ? colorectal cancer Jonsson Comprehensive Cancer Center Unknown No outcome recorded
Phase 21 trial
Phase 2 NCT00004902 Jan 1998 → Nov 1999 plasma cell myeloma Northwestern University Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as tocladesine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004902 ↗
1

NCT00021268 ↗

Known as 8-chloro cyclic amp ChEMBL registry synonym — accepted as the source's own label CHEMBL2107085 ↗
Known as 8-CL-CAMP ChEMBL registry synonym — accepted as the source's own label CHEMBL2107085 ↗
Known as Adenazole ChEMBL registry synonym — accepted as the source's own label CHEMBL2107085 ↗
Known as ICN-1256 ChEMBL registry synonym — accepted as the source's own label CHEMBL2107085 ↗
Known as NSC-284751 ChEMBL registry synonym — accepted as the source's own label CHEMBL2107085 ↗
Known as NSC-614491 ChEMBL registry synonym — accepted as the source's own label CHEMBL2107085 ↗
Known as Tocladesina ChEMBL registry synonym — accepted as the source's own label CHEMBL2107085 ↗
Modality Small molecule — CHEMBL2107085 ↗
Route Intravenous “tocladesine IV continuously” NCT00021268 ↗